Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats

Proceedings of the Society for Experimental Biology and Medicine

Volumn 217, Issue 3, 1998, Pages 358-364

  Lamartiniere, Coral A ^a   Murrill, W Britton ^a   Manzolillo, Patricia A ^a   Zhang, J X ^a   Barnes, Stephen ^a   Zhang, Xueshu ^b   Wei, Huachen ^b   Brown, Nadine M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; DNA; ESTROGEN; GENISTEIN; PHYTOESTROGEN; SEX HORMONE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BREAST CANCER; BREAST DEVELOPMENT; CONTROLLED STUDY; DIET; ESTRUS CYCLE; FEMALE; MAMMARY GLAND; NEWBORN; NONHUMAN; ONTOGENY; OVARY FOLLICLE DEVELOPMENT; PROTECTION; RAT; SOYBEAN;

ANIMALIA; GLYCINE MAX; RODENTIA;

EID: 0031935097     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-217-44245     Document Type: Article

References (63)

1. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet 337:1197-1200, 1991.
2. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, Hasegawa T, Okada H. Urinary excretion of ligands and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54:1093-1100, 1991.
3. Shutt DA, Cox RI. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J Endocrinol 52:299-310, 1972.
4. Mathieson RA, Kitts WD. Binding of phytoestrogen and estradiol-17β by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe. J Endocrinol 85:317-325, 1980.
5. Martin PM, Horowitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103:1860-1867, 1978.
6. Mäkelä S, Davis VL, Tally WC, Korkman J, Salo L, Vihko R, Santti R, Korach KS. Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect 102:572-578, 1994.
7. Cheng E, Story CD, Yoder L, Hale WH, Burroughs W. Estrogenic activity of isoflavone derivatives extracted and prepared from soybean oil meal. Science 118:164-165, 1980.
8. Bickoff EM, Livingston AL, Hendrickson AP, Booth AN. Relative potencies of several estrogen-like compounds found in forages. J Agric Food Chem 10(5):410-412, 1962.
9. Folman Y, Pope GS. The interaction in the immature mouse of potent estrogens with coumestrol, genistein, and other utero-vaginotrophic compounds of low potency. J Endocrinol 34:215-225, 1966.
10. Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Val12] Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 157:183-189, 1988.
11. Tripathi YB, Lim RW, Fernandez-Gallardo S, Kandala JC, Guntaka RV, Shukla SD. Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A-431 cells. Biochem J 286:527-533, 1992.
12. Dean NM, Kanemitsu M, Boynton AL. Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells. Biochem Biophys Res Commun 165:795-801, 1989.
13. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595, 1987.
14. Jha HC, von Recklinghouse G, Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem Pharmacol 34:1367-1369, 1985.
15. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90:2690-2694, 1993.
16. Gyorgy P, Murata K, Ikehata H. Antioxidants isolated from fermented soybeans (tempeh). Nature 204:870-872, 1963.
17. Pratt DE, Di Pietro C, Porter WL, Giffee JW. Phenolic antioxidants of soy protein hydrolyzates. J Food Sci 47:24-25, 1981.
18. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and anti-promotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208:124-130, 1995.
19. Constantinou A, Kiguchi K, Huberman E. Induction of differentiation and DNA strand breakage in human HL-60 and K562 leukemia cells by genistein. Cancer Res 50:2618-2624, 1990.
20. Kiguchi K, Constantinou A, Huberman E. Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells. Cancer Commun 2:271-278, 1990.
21. Watanabe T, Kondo K, Oishi M. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Cancer Res 51:764-768, 1991.
22. Kondo K, Tsuneizumi K, Watanabe T, Oishi M. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases. Cancer Res 51:5398-5404, 1991.
23. Miller DR, Lee GM, Maness PF. Increased neurite outgrowth induced by inhibition of protein tyrosine kinase activity in PC 12 pheochromocytoma cells. J Neurochem 60:2134-2144, 1993.
24. Constantinou A, Huberman E. Genistein as an inducer of tumor cell differentiation: Possible mechanisms of action (43841). Proc Soc Exp Biol Med 208(1):109-115, 1995.
25. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, Chelstrom LM, Burkhardt A, Bolen J, Myers DE. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267:886-891, 1995.
26. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 347:239-253, 1990.
27. Lamartiniere CA. Imprinting and biochemical insult. An invited presentation to Perinatal Carcinogenesis Workshop at National Cancer Institute, Frederick, MD, 1990.
28. Lamartiniere CA, Holland MB. Neonatal diethylstilbestrol prevents spontaneously developing mammary tumors. In: JJ Li, S Nandi, SA Li, Eds. Hormonal Carcinogenesis. New York: Springer Verlag, pp305-308, 1992.
29. Herbst AL, Scully RE. Adenocarcinoma of the vagina in adolescence: A report of seven cases including six clear cell carcinomas (so called mesonephromas). Cancer 25:745-757, 1970.
30. McLachlan JA, Newbold RR, Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 40:3988-3999, 1980.
31. Takamatsu Y, Iguchi T, Takasugi N. Effects of neonatal exposure to diethylstilbestrol on protein expression by vagina and uterus in mice. In Vivo 6:1-8, 1992.
32. Sato T, Okamura H, Ohta Y, Hayashi S, Takamatsu Y, Takamatsu N, Iguchi T. Estrogen receptor expression in the genital tract of female mice treated neonatally with diethylstilbestrol. In Vivo 6:151-156, 1992.
33. Lamartiniere CA, Moore J, Holland M, Barnes S. Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 208:120-123, 1995.
34. Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis 16:2833-2840, 1995.
35. Murrill WB, Brown NM, Manzolillo PA, Zhang JX, Barnes S, Lamarliniere CA. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17:1451-1457, 1996.
36. Lamartiniere CA. Neonatal estrogen treatment alters sexual differentiation of hepatic histidase. Endocrinology 105:1031-1035, 1979.
37. Lamartiniere CA, Sloop CA, Clark J, Tilson HA, Lucier GW. Organizational effects of hormones and hormonally-active xenobiotics on postnatal development. In: 12th Conference on Environmental Toxicology, Dayton, Ohio, U.S. Air Force Publication: AFAMRL-TR-81-149, pp96-121, 1982.
38. McEwen BS. Interactions between hormones and nerve tissue. Sci American 235:48-58, 1976.
39. Gorski RA, Gordon JH, Shryne JE, Southam AM. Evidence for a morphological sex difference within the medial preoptic area of the rat brain. Brain Res 148:333-346, 1978.
40. Weisz J, Gibbs C. Conversion of testosterone and androstenedione to estrogens in vitro by the brain of female rats. Endocrinology 94:616-620, 1974.
41. Gustafsson JA, Mode A, Norstedt G, Hohfelt T, Sonnenschein C, Eneroth P, Skett P. In: G. Litwack, Ed. Biochemical Actions of Hormones, Vol. 7. New York: Academic Press, pp47-90, 1980.
42. Russo IH, Russo J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7, 12-dimethylbenzanthracene. J Natl Cancer Inst 61:1439-1449, 1978.
43. Russo IH, Tewari M, Russo J. Morphology and development of the rat mammary gland. In: TC Jones, Y Konishi, U Mohr, Eds. Integument and Mammary Gland: Monograph Series on the Pathology of Laboratory Animals. Berlin: Springer-Verlag, 1988.
44. Russo J, Russo IH. DNA labelling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J Natl Cancer Inst 61:1451-1459, 1978.
45. Nagasawa H, Yanai R, Taniguchi H. Importance of mammary gland DNA synthesis on carcinogen induced mammary tumorigenesis in rats. Cancer Res 36:2223-2226, 1976.
46. Russo J, Russo IH. Biology of disease. Biological and molecular bases of mammary carcinogenesis. Lab Invest 57:112-137, 1987.
47. Berenblum I. A speculative review: The probable nature of promoting action, and its significance in the understanding of the mechanism of carcinogenesis. Cancer Res 14:471-476, 1954.
48. Russo J, Russo IH. Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res 40:2677-2687, 1980.
49. Strauss W. Preparation of genomic DNA from mammalian tissue. In: Ausubel FM, Eds. Current Protocols in Molecular Biology. New York: John Wiley and Sons, Inc., pp 2.2.1-2.2.3, 1994.
50. 32P-postlabeling analysis of non-radiactive aromatic carcinogen-DNA adducts. Carcinogenesis 3:1081-1092, 1982.
51. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7:1543-1551, 1986.
52. Cai Q, Wei H. In vivo formation of DNA-adducts in mouse skin DNA by tamoxifen. Cancer Lett 92:187-192, 1995.
53. Giri AK, Lu L-J W. Genetic damage and the inhibition of 7,12-dimethylbenz(a)anthracene-induced genetic damage by the phytoestrogens, genistein and diadzein, in female ICR mice. Cancer Lett 95:125-133, 1995.
54. Cassidy A, Bingham S, Setchel KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60:333-340, 1994.
55. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 12: 77-126, 1970.
56. Ferguson DJ, Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer 44:177-181, 1981.
57. Olsson H, Landin-Olsson M, Gullberg B. Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease. J Natl Cancer Inst 70:17-20, 1983.
58. Adlercreutz H. Western diet and western diseases: Some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 50(201):3-23, 1990.
59. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phytoestrogens in Japanese men. Lancet 342:1209-1210, 1993.
60. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S. Age at first birth and breast cancer risk. Bull World Health Organ 43:209-221, 1970.
61. Shellabarger O, Soo VA. Effects of neonatally administered sex steroids on 7, 12-dimethylbenz(a)anthracene-induced mammary neoplasia in rats. Cancer Res 33:1567-1569, 1973.
62. Nagasawa H, Yanai R, Shodono M, Nakamura T, Tanabe Y. Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17β level in rats. Cancer Res 34:2643-2646, 1974.
63. Russo IH, Koszalka M, Russo J. Effect of human chorionic gonadotropin on mammary gland differentiation and Carcinogenesis. Carcinogenesis 11:1849-1855, 1990.